Among 13 evaluable patients with sufficient baseline/archival tumor tissue for testing, PD-L1 tumor proportion score (TPS) was 0% for 8 (62%), >1–50% for 4 (31%), and >50% for 1 (8%) (Supplemental Fig. 1, Fig. 1D). The gene discussed is CD274; the disease is neoplasm.